Prostate Cancer International is
for 2011 by Great NonProfits
Perspective Confidentiality Disclosure Reliability Courtesy
A new report from an Italian clinical research team, and based on a randomized clinical trial of 300 patients, suggests that color Doppler ultrasound offers no significant benefit over standard “gray-scale” ultrasound in the biopsy-based diagnosis of prostate cancer — which is not going to please the advocates of color Doppler ultrasonography.
Filed under: Diagnosis, Risk | Tagged: biopsy, color Döppler, Diagnosis, guidance, SonoVue, transrectal, ultrasound | 4 Comments »
A new paper in Urologic Oncology, taken in combination with a media release and a video release from the UCLA Health System, have described a sophisticated method of combining data from magnetic resonance imaging (MRI) of the prostate with a three-dimensional (3D) ultrasound system to optimize outcomes of prostate biopsies.
Filed under: Diagnosis, Management, Risk | Tagged: Artemis, biopsy, magnetic resonance imaging, MRI, three-dimensional, tracking, transrectal, ultrasound | Leave a Comment »
For many years a relatively small group of specialists have argued that “enhanced” types of transrectal ultrasound technology (most specifically inclusive of color Döppler ultrasound) have a greater ability to identify possible signs of prostate cancer than traditional “gray-scale” ultrasound.
Filed under: Diagnosis | Tagged: biopsy, detection, Diagnosis, ultrasound | 4 Comments »
Here in the USA there has been a nucleus of physicians who have argued for years that the use of color Doppler ultrasound enhances the ability to identify and biopsy prostate cancer. New data from Germany are relevant to this conversation.
Filed under: Diagnosis, Management | Tagged: biopsy, color Döppler, systematic, ultrasound | 2 Comments »
There have been a number of interesting reports over the past couple of days that are summarized briefly below. They encompass such topics as: The validity of the Epstein criteria in predicting clinically indolent prostate cancer MRI and MRSI in patient work-up prior to treatment for stage T1c disease Contrast-enhanced, color Döppler ultrasound and prostate [...]
Filed under: Uncategorized | Tagged: ADT, age, androgen deprivation therapy, color Döppler, comorbidities, Epsetin criteria, Gleason score, magnetic resonance, mortality, MRI, MRSI, testosterone, ultrasound, unilateral | 2 Comments »
Search for new and
ongoing trials on the
CTAG PCa web site